1. Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations
   WEI LU et al, 2015 CrossRef
2. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells.
   H Ruan et al, 2017, Oncogene CrossRef
3. Connexin 32 affects doxorubicin resistance in hepatocellular carcinoma cells mediated by Src/FAK signaling pathway
   Meiling Yu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
4. null
   Alok Chandra Bharti et al, 2018 CrossRef
5. Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer
   Chen Shaojun et al, 2017, Cancer Biology & Therapy CrossRef
6. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
   Meiling Yu et al, 2017, Biomed Pharmacother CrossRef
7. Differential effect of psoralidin in enhancing apoptosis of colon cancer cells via nuclear factor-κB and B-cell lymphoma-2/B-cell lymphoma-2-associated X protein signaling pathways
   ZHILIANG JIN et al, 2016 CrossRef
8. Berberine, an Epiphany Against Cancer
   Luis Guamán Ortiz et al, 2014, Molecules CrossRef
9. Synergetic Inhibition of Human Colorectal Cancer Cells by Combining Polyyne-Enriched Fraction from Oplopanax elatus and Irinotecan
   Jin Wang et al, 2018, Nutrition and Cancer CrossRef
10. Drug resistance in topoisomerase-targeting therapy
    Karol Wtorek et al, 2018, Postepy Hig Med Dosw CrossRef
11. Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation
    K. I. Kirsanov et al, 2019, Usp. mol. onkol CrossRef
12. Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy
    Warowicka Alicja et al, 2019, Phytomedicine CrossRef
13. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system
    Kun Zou et al, 2017, Acta Pharmacol Sin CrossRef
14. Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration
    Michael D Burkitt et al, 2017, Cell Death Dis CrossRef
15. null
    Priya Katyal et al, 2019 CrossRef
16. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
    Parham Jabbarzadeh Kaboli et al, 2014, European Journal of Pharmacology CrossRef
17. Survivin as a Target for Anti-cancer Phytochemicals According to the Molecular Docking Analysis
    Kobra Foroughi et al, 2019, Int J Pept Res Ther CrossRef
18. Growth-suppressive effect of berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway
    Han-Peng Kuo et al, 2015, Journal of Functional Foods CrossRef
19. Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents
    Jiaolin Bao et al, 2015, PLoS ONE CrossRef
20. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
    Ning Wang et al, 2015, Journal of Ethnopharmacology CrossRef
21. UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
    Chunlei Xu et al, 2016, Cancer Chemother Pharmacol CrossRef
22. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Xue Zhang et al, 2017, Cancer Chemother Pharmacol CrossRef
23. Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine
    Yulin Zhang et al, 2017, Chin Med CrossRef
24. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78
    Chenxue Gong et al, 2020, Anti-Cancer Drugs CrossRef
25. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer
    Jamal Hallajzadeh et al, 2020, Med Oncol CrossRef
26. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells
    Ge Li et al, 2021, Pharmaceutical Biology CrossRef
27. Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
    Nalini Devarajan et al, 2021, Phytotherapy Research CrossRef
28. Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
    Bo-Ram Jin et al, 2021, Aging CrossRef
29. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
    Sajad Fakhri et al, 2022, Front. Oncol. CrossRef
30. Evidence for Anticancer Effects of Chinese Medicine Monomers on Colorectal Cancer
    Tian-hao Guo et al, 2022, Chin. J. Integr. Med. CrossRef
31. Enhancement of Sensitivity to Tamoxifen by Berberine in Breast Cancer Cells by Inhibiting ER-α36 Expression
    Xiaohua Pan et al, 2022, Iran J Pharm Res CrossRef
32. Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota
    Qiang Sun et al, 2022, Phytomedicine CrossRef
33. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
    Saleh A. Almatroodi et al, 2022, Molecules CrossRef
34. Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
    Keisuke Okuno et al, 2022, Pharmaceuticals CrossRef
35. The therapeutic effects of berberine for gastrointestinal cancers
    Amirhossein Davoodvandi et al, 2023, Asia-Pac J Clncl Oncology CrossRef
36. Berberine enhances the therapeutic effect of 5-fluorouracil in Caco-2 colorectal adenocarcinoma cells by alleviating inflammation and inducing apoptosis
    Seyma ONCU et al, 2023, Cukurova Med J CrossRef
37. Current trends and future prospects of drug repositioning in gastrointestinal oncology
    Nayeralsadat Fatemi et al, 2024, Front. Pharmacol. CrossRef
38. Synergy between human DNA ligase I and topoisomerase 1 unveils new therapeutic strategy for the management of colorectal cancer
    Pooja Maurya et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
39. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer
    Ze Rong et al, 2024, J Cancer Res Clin Oncol CrossRef
40. Berberine: Potential preventive and therapeutic strategies for human colorectal cancer
    Yuqian Feng et al, 2024, Cell Biochemistry & Function CrossRef
41. Unlocking the Potential of Berberine: Advancing Cancer Therapy through Chemosensitization and Combination Treatments
    Anjana Sajeev et al, 2024, Cancer Letters CrossRef
42. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease
    Caroline Coppinger et al, 2024, CRCEP CrossRef
43. The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment
    Yan Luo et al, 2024, Molecules CrossRef
44. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
    Solomon Habtemariam, 2020, Molecules CrossRef